Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.
Qiagen N.V. fournit des solutions d'échantillon à analyse qui transforment les échantillons biologiques en informations moléculaires dans le monde entier.
Traduit automatiquement
Voir les graphiques interactifs et les états complets → Modèle de valorisation (DCF) →
| Compte de résultat | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiffre d'affaires total | $2.1B | $2.1B | $2.0B | $2.0B | $2.1B | $2.3B | $1.9B | $1.5B | $1.5B | $1.4B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.1B | $1.0B | $893M | $650M | $466M |
| Bénéfice brut | $1.3B | $1.3B | $967M | $1.2B | $1.4B | $1.5B | $1.2B | $1.0B | $1.0B | $923M | $845M | $827M | $865M | $815M | $824M | $750M | $716M | $667M | $600M | $434M | $325M |
| Marge brute % | 61.8% | 61.8% | 48.9% | 62.8% | 64.6% | 64.4% | 65.9% | 65.9% | 66.6% | 65.1% | 63.1% | 64.5% | 64.3% | 62.6% | 65.7% | 64.1% | 65.8% | 66.1% | 67.2% | 66.7% | 69.7% |
| Résultat opérationnel (EBIT) | — | $520M | $98M | $410M | $531M | $630M | $386M | ($26M) | $267M | $153M | $99M | $179M | $162M | $63M | $170M | $100M | $189M | $180M | $146M | $83M | $101M |
| Marge opérationnelle % | — | 24.9% | 4.9% | 20.9% | 24.8% | 28.0% | 20.7% | -1.7% | 17.8% | 10.8% | 7.4% | 14.0% | 12.0% | 4.9% | 13.5% | 8.5% | 17.3% | 17.8% | 16.3% | 12.8% | 21.6% |
| Résultat net | $409M | $425M | $84M | $341M | $423M | $513M | $359M | ($41M) | $190M | $40M | $80M | $130M | $116M | $69M | $130M | $96M | $144M | $138M | $89M | $50M | $71M |
| Marge nette % | 19.5% | 20.3% | 4.2% | 17.4% | 19.8% | 22.8% | 19.2% | -2.7% | 12.7% | 2.9% | 6.0% | 10.2% | 8.6% | 5.3% | 10.3% | 8.2% | 13.3% | 13.6% | 10.0% | 7.7% | 15.1% |
| EBITDA | — | $717M | $368M | $689M | $779M | $895M | $716M | $228M | $499M | $381M | $309M | $365M | $360M | $268M | $366M | $289M | $344M | $322M | $263M | $195M | $140M |
| Bénéfice par action (EPS) | $1.95 | $2.04 | $0.38 | $1.57 | $1.90 | $2.28 | $1.58 | $-0.19 | $0.82 | $0.17 | $0.35 | $0.57 | $0.50 | $0.30 | $0.56 | $0.42 | $0.62 | $0.67 | $0.45 | $0.30 | $0.48 |
| Actions en circulation (M) | — | 208M | 218M | 217M | 223M | 225M | 227M | 220M | 233M | 233M | 230M | 228M | 233M | 233M | 232M | 230M | 232M | 206M | 197M | 169M | 148M |
Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.
Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de QGEN. /companies/us/QGEN
Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.
About TickerBase · Data methodology & sources · Privacy · Terms